4367 |
TR Treatment Through Catheter: Forma, Triliagn, and Cardioband |
Darren L. Walters |
Aug. 11. 17 |
4366 |
Peri- and Post-Antithrombotics TAVR |
Raj Makkar |
Aug. 11. 17 |
4365 |
Coronary or Cerebral Protection: When and How? |
Eberhard Grube |
Aug. 11. 17 |
4364 |
Sizing Strategy and PVL Management: Most Experienced Strategy |
Alan C. Yeung |
Aug. 11. 17 |
4363 |
Standard vs. Minimalist TAVR: When and How to Change? |
Duk-Woo Park |
Aug. 11. 17 |
4362 |
Heart Team Decision-Making: How to Collaborate in Reality? |
Kentaro Hayashida |
Aug. 11. 17 |
4361 |
TAVR for Low Risk Patients: Surgeon\'s Viewpoint |
Jian (James) Ye |
Aug. 11. 17 |
4360 |
TAVR for Low Risk Patients: Interventionist\'s Viewpoint |
Alan C. Yeung |
Aug. 11. 17 |
4359 |
TAVR Outcome Issues: Thrombosis and Durability |
Raj Makkar |
Aug. 11. 17 |
4358 |
Complex TAVR for Specific Challenging Cases - How to Do in Practice? |
Eberhard Grube |
Aug. 11. 17 |